Table 2

Female Mycoplasma genitalium prevalence at year 2 by trial arm (intention-to-treat analysis) and circumcision status (as-treated analysis)

Intervention groupControl groupPRR (95% CI)adjPRR (95% CI)*
MG positive/N%MG positive/N%
Intention-to-treat
 14/4373.214/3943.60.90 (0.43 to 1.89)0.93 (0.43 to 2.03)
As-treated
 14/4133.414/4183.31.01 (0.48 to 2.12)1.00 (0.46 to 2.18)
  • *Adjusted for age, treatment for vaginal discharge, dysuria, or genital ulcers at the mid-point trial visit (year 1), and the year 2 follow-up number of sex partners (1 vs >1), condom use, non-marital relationships and transactional sexual intercourse.

  • MG, Mycoplasma genitalium.